AIM: We studied actual treatments in relation to preferences for starting or forgoing treatment of older people at the end of life.
INTRODUCTION
Decisions concerning starting or forgoing life-prolonging treatments have to be made for many patients at the end of life. Studies in different population showed that the majority of patients prefer treatments to be forgone at the end of life [1] [2] [3] [4] [5] [6] [7] . In some studies a general preference was asked (for instance 'symptom directed care' versus ' life-prolonging care', or 'symptom relief only') [1] [2] [3] 6 . Other studies asked for preferences for specific treatments (such as resuscitation or artificial nutrition and hydration) 4, 5, 7 . If patients have preferences concerning starting or forgoing treatments at the end of life, it is important that others know these preferences because only then they can be acted upon. People may discuss their preferences with others (advance care planning (ACP)), and/or write them down in a written statement (an advance directive (AD)). Two recent studies among advanced cancer patients in the US 1, 3 found that two thirds of the patients received care consistent with their preference -defined as treatment focused on life extension versus care focused on relieving pain and discomfort (85%) than in patients who preferred life-extending treatments (26%) 3 . A study among older patients with different advanced diseases in the US also found that concordance between preferred and received care was much higher for patients with lower willingness to undergo intensive treatment; meaning that the majority of mismatches resulted in less treatment than desired 2 . Similar results were found in a study amongst proxies of incapacitated older adults with a living will in the US 6 . This study showed that when preferences for receiving comfort care and receiving limited care was known, they were mostly followed (97% and 83% respectively), and that a known preference for receiving all possible care was followed in half of the patients. Recent studies that concentrated on older people in long-term care facilities in the US also found that preferred and received care were mostly in concordance, but that this varied between specific treatment decisions 4, 5 . Biola et al. 4 studied specific treatments and found that concordance was high for tube feeding (6/7, 86% of patients whose preference was known) and antibiotics (63/78, 81%), but low for resuscitation (2/7, 29%). Hickman et al. 5 specifically studied concordance between treatments provided and POLST (Physician Orders for Life-Sustaining Treatment) treatment orders and found that concordance was over 90% for resuscitation and antibiotics, and 64% for tube feeding. Thus, the few concordance studies show little agreement.
Several studies have shown the effect of advance care planning on preferences known and followed. Two randomized controlled trials on facilitated advance care planning, one in Australia in older hospitalized patient and one in the US in patients with congestive heart failure or end-stage renal disease, showed no differences between patients in the intervention group and control group regarding preferences followed if preferences were known 8, 9 . However, preferences were more often known in patients who received facilitated advance care planning 8 . A study in the US on patients who died in a nursing home, hospital or at home found that patients with an AD more often had specific wishes for care, compared to patients without an AD, though they found no differences in care consistent with wishes between patients with known wishes with and without an AD 10 .
We conducted a study about preferences and actual treatment at the end of life in the general older population in the Netherlands. We concentrated on the most commonly made (non) treatment decisions at the end of life; namely decisions on resuscitation, artificial nutrition/hydration (ANH), antibiotics and artificial respiration [11] [12] . We studied how often known preferences were followed, and what was decided if no preference was known as well as factors associated with preferences being followed and factors associated with the decision to forgo treatment.
METHODS

Study design and sample
Our sample consisted of deceased participants of two cohort studies. A representative sample of the Longitudinal Aging Study Amsterdam (LASA), and a purposive sample of the advance directive cohort study (ADC). The cohort members died between 2006-2009. As LASA is a cohort of older people, and the youngest deceased participant of the LASA cohort was 57, we selected deceased ADC participants from age 57 and up (omitting 9 members). Data on the last three months of life of the deceased were collected by a written questionnaire sent to a close relative. The study design was approved by the Medical Ethical Committee of the VU University medical center.
LASA sample members
LASA is a random population-based cohort stratified by age and gender, and drawn from the population registers of 11 municipalities in the Netherlands to reflect the national distribution of urbanization and population density. The LASA sample was recruited in 1992-1993 and an additional cohort of people aged 55-65 years was recruited in 2002-2003 (total n=4109). Data collection was carried out every three years. The design of the LASA study is described more extensively elsewhere 13 .
ADC sample members
The advance directive cohort is based on a sample of 5561 people who have requested an AD from the Right to Die-NL (NVVE), and 1261 people who have formulated an AD from the Christian Dutch Patient Association (NPV). Most common ADs in the Netherlands were developed by these two organizations. The NVVE provides four ADs: a refusal of treatment document, an advance euthanasia directive, a do not resuscitate order, and a document to appoint a health care proxy. The NPV provides a will-to-live statement in which a person declares a wish to receive no excessive, medically futile end-of-life treatment and no actions with the purpose of hastening the end of life. The first measurement was in 2005 with follow-ups every one and a half years. The design of the ADC study is described more extensively elsewhere 14 .
relatives of deceased cohort members
For the deceased sample members we checked who had given permission to contact a named relative after their death; in both cohorts this was asked when starting the cohort. If this permission was given, we sent a letter to the relative to ask whether they were willing to participate in the study via an answering card. The data collection took place in 2009-2010. In the LASA cohort 311 participants died between 2006-2009 and had given permission to contact a proxy. We approached 284 proxies, as 27 proxies could not be found. A total of 168 proxies completed the questionnaire (59%), 69 proxies (25%) did not respond and 47 proxies (17%) did not want to participate. Of the ADC participants 263 died between 2006-2009 and had given permission to contact a proxy. We approached 256 proxies, as 7 proxies could not be found. A total of 184 proxies completed the questionnaire (72%), 52 proxies (20%) did not respond and 20 proxies (8%) were not willing to participate. Proxies of the deceased LASA members were predominantly a child of the deceased member (83%), followed by a partner (7%), another family member (5%), and non-relative (e.g. friend) (5%). Proxies of the deceased ADC members were a child of the deceased member (53%), a partner (39%), another family member (6%) and a non-relative (2%). The relationship between respondent and deceased differed significantly between the LASA and ADC cohorts.
Measures
The proxy questionnaire consisted of structured questions including the sample member's age, gender, education, partner status, religious beliefs, cause of death, possession of an AD, and specialty of attending physician. Three questions were asked about four different (non) treatment decisions: 1) Did your relative have specific wishes for starting or forgoing a) resuscitation, b) artificial nutrition/hydration, c) antibiotics, and d) artificial respiration in specific situations three months prior to death? And if yes, what were these wishes (starting or forgoing specific treatment)?
2) In the last three months prior to death, did your relative -a) have a cardiac arrest? -b) have problems with eating and drinking, for which a decision concerning ANH was necessary? -c) have a pneumonia, for which a decision concerning antibiotics was necessary? -d) have difficulty breathing, for which a decision concerning artificial respiration was necessary? 3) If yes, did your relative receive a) resuscitation, b) ANH, c) antibiotics, d) artificial respiration?
Analyses
For describing the characteristics of the patients, we classified people as 'sample with known preference' when their relative had answered that the patient had specific wishes for at least one of the four treatment decisions (question 1). If the actual decision was in accordance with this preference (Figure 1 ), we selected people whose relative had answered yes on the question 2a through 2d. To analyze the possible factors associated with the actual decision being in accordance with preferences, we selected the patients with known preferences who had been in a situation where one or more of the four studied decisions had to be taken. To analyze possible factors associated with forgoing treatment we selected patients who had been in a situation in which this decision had to be taken (whether or not their preference was known). We performed backward logistic regression analysis with 'decision being in accordance with preference' as the dependent variable for the first analysis, and with 'treatment being forgone' as the dependent variable in the second analysis. For both dependent variables, only independent variables that differed with p<0.1 regarding the dependent variable were entered into the regression. Independent variables with the highest p-value were removed until all variables remained significant (p<0.05). Table 1 shows that people with a preference known by the proxy more often died before the age of 85, were more often higher educated, more often died of cancer or a heart disease and more often had completed an advance directive compared to people without a preference known by the proxy. People without a known preference more often had religious beliefs, were incompetent for more than one week before death, and died of old age, stroke or dementia compared to people with a known preference. No significant differences were found between people with and without known preferences for gender and partner status. Concerning the situations in which a decision to start or forgo treatment was necessary, problems with eating and drinking, for which a decision concerning ANH was necessary occurred most often (27% and 20% respectively in people with and without a known preference), followed by pneumonia, for which a decision concerning antibiotics was necessary (25% and 18% respectively in people with and without a known preference). Figure 1 shows that in most patients who preferred to receive treatment in a specific medical situation, this preference was followed (100% for resuscitation, 88% for ANH, 90% for antibiotics, and 100% for artificial respiration). In about half of the patients who preferred that a treatment would be forgone, this preference was followed, except for artificial respiration, for which concordance between preferred and actual treatment was lower (50% for resuscitation, 60% for ANH, 60% for antibiotics, and 12% for artificial respiration) The majority of people for whom no preference was known received treatment in these scenarios (63% for resuscitation, 59% for ANH, 79% for antibiotics, and 67% for artificial respiration). * Missings in all groups of all variables were less than 5% of the total n. † Sample with known preference consists of 97 LASA sample members, 148 NVVE members and 12 NPV members. Sample without known preference consists of 71 LASA sample members, 12 NVVE members and 3 NPV members. ‡ Difference between people with and without known preference is significant (p<0.05). ¶ More than one answer could be given. Bold type indicates significance. * Selection of older population who had been in a situation in which an actual decision on starting or forgoing of treatment had to be made and who had a known preference concerning this decision. † Missing were less than 5% for all variables. ‡ Dependent variable: actual decision was in accordance with preferences (n=73); reference group: actual decisions was not in accordance with preferences (n=23). ¶ p>0.10 in univariate logistic regression; not entered in multivariate logistic regression. ¶ ¶ Entered in multivariate logistic regression, but did not remain significant. ** For advance directive no logistic regression could be made as of all 24 people without AD the preference was followed; entering in the multivariate analyses would be debatable also since having an AD is strongly related to preferring non-treatment: 93% of people who did not want treatment had an AD.
RESULTS general characteristics
Actual decisions in relation to the patient's preferences
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Factors associated with decisions in accordance with preferences
Univariate analyses among 99 patients who had been in a situation where a decision on whether or not starting a treatment had to be taken, and whose preference about it three months before death was known, showed that people with a religious belief (OR 3.5), not being incompetent before the last week of life (OR 2.9), and having a known preference to receive the treatment (OR 7.4) meant that the accordance with their preference was more likely. However, in the multivariate analyses only the preference to receive the treatment (as opposed to forgoing the treatment) remained significant, with increased odds of preference being met (OR 7.4; Table 2 ).
Factors associated with decisions to forgo treatments
In the 148 patients who had been in a situation in which a decision had to be taken (whether or not their preference was known), three significant characteristics were related to the decision to forgo treatment. Compared to patients for whom a general practitioner was the attending physician, people attended by a medical specialist had less (OR 0.23), and people attended by a nursing home physician had more (OR 2.9) chance of forgoing a treatment. Compared to having no known preference people with a preference for forgoing a treatment had higher odds (OR 6.3), and people with a preference for starting a treatment had lower odds (OR 0.28) on treatment being forgone. Finally, people for whom a decision on artificial respiration had to be taken had lower odds (OR 0.08) for this treatment being forgone (Table  3) . Bold type indicates significance. * Selection of older people who had been in a situation in which an actual decision on starting or forgoing of treatment had to be made (excluding 13 people for whom treatment was given for one treatment and treatment was forgone in another treatment). † Missing were less than 5% for all variables. ‡ Dependent variable: actual decision was in accordance with preferences (n=73); reference group: actual decisions was not in accordance with preferences (n=23). ¶ p>0.10 in univariate logistic regression; not entered in multivariate logistic regression. ¶ ¶ Entered in multivariate logistic regression, but did not remain significant.
DISCUSSION
Decision-making more in accordance with preferences for starting treatment than for forgoing treatment Our study shows that older people who have a known preference for receiving life-prolonging treatment, have a (seven times) higher chance that their preference is followed, than older people who have a known preference not to be treated. This finding is contradictory to the findings in other studies cited in the introduction, in which concordance between preferred and received care was much higher in patients who preferred less life-prolonging care than in patients who preferred to receive life-prolonging treatments 2, 3 . The difference in more 'conservative' care in these studies and more 'aggressive' care in our study might be due to differences in populations. These other studies concerned patients in advanced stages of diseases (mainly cancer, but also advanced stages of heart failure and COPD). Possibly, in many patients, life-prolonging treatments such as chemotherapy were not available anymore 2 . It is also possible that in these patients the goal of care had shifted from curative care to palliative care, with the main focus on comfort and symptom control, which makes it 'logical' that life-prolonging treatments are being forgone. In our study sample (older people of the general population who had died), treatment options were possibly still available in most patients who preferred active treatment, and was therefore given if patients preferred it. However, it is also possible that physicians had not recognized that patients who wanted to be treated were near the end of life, and the main goal of care was still curative instead of palliative care. However, this does not necessarily explain the lack of concordance we found in patients who preferred forgoing treatment. This treating 'against the patient's wish' was also found in the studies cited in the introduction, but in a variety of percentages [2] [3] [4] [5] . In these patients it is possible that the physicians had recognized the palliative phase and started palliative care, in which forgoing potential life prolonging treatment may not have been seen as the best option when it comes to comfort care 5 . It is also possible that the patients' preferences had changed near the end of life. Kirchhoff et al. found in their study that some patients altered their preferences to be in accord with the care they could receive 9 . However, we know from earlier analyses that most people in our cohorts did not show differences in treatment preferences at three months and three days before death 15 . Yet, it is possible that patients changed their preference from forgoing treatment to receiving treatment at the very moment that the patient was in the situation that the decision had to be taken. Lastly, it is possible that the physician did not know the preference of the patient.
Making your preferences for (non) treatment known is useful
People who had a known preference for forgoing treatment had a much higher chance that treatment indeed would be forgone, compared to people in whom no preference was known, and people who had a known preference for starting treatment had a much lower chance that treatment would be forgone compared to people in whom no preference was known. Similar results were found by Silveira et al. 6 . This indicates that making one's preference known is useful. However, surprisingly, we did not find an association between the decision being in accordance with preference and preference having been discussed with physician, while Mack et al. 1 found that patients who had discussed their wishes were more likely to receive care consistent with wishes. Teno et al. 10 found that persons who did not have an AD but who had expressed wishes regarding end-of-life care exhibited similar patterns of use of life-sustaining treatment as those with a written AD. Likewise, we did not find that having an AD increases the chance of treatment being forgone. However, in an earlier study we did find that ADs seem to have a role in starting discussions about preferences and thus in making sure that preferences are known 15 . Thus having an AD serves at least this purpose.
other findings
We found that people with and without known preferences differed on several characteristics (age, level of education, religious beliefs, cause of death, incompetence for more than a week, having an AD and type of AD). Some of these differences may be the result of the different illness trajectories. For instance, people having a progressive life-limiting disease, such as cancer, often have a clear moment to start to think and talk about wishes at the end of life (and writing them down in ADs), whereas people with diseases with a more prolonged gradual decline, such as dementia or 'old age', have a less clear moment of starting to discuss preferences for the end of life 16 . The latter are probably also more at risk to become incompetent at the end of life, and are older of age. However, none of these characteristics were found to be associated with preferences being followed or decisions to forgo treatment. We only found, next to making your preferences known, that people for whom a nursing physician was the attending physician had a higher chance of treatment forgone, compared to patients for whom a general practitioner was attending. This probably reflects the care given in nursing homes, where patients often are near the end of life, and quality of life often prevails over quantity of life.
strengths and limitations
This study has some limitations. First, we know the patient's preference only via the proxy, which is not necessarily in accordance with their actual preference. Moreover, as previously mentioned, it is possible that patients changed their preference at the moment of deciding, which means a possible overestimation of mismatches. Furthermore, recall bias may be present in the data due to retrospective reporting: the sample members died between six months to three years before the proxies entered the study. Nevertheless, it is plausible that proxies remember the circumstances around the death of a relative accurately 17, 18 . A strength of our study is the combination of a cohort representative for the Dutch older population with a purposive cohort representative for people with an AD, as the second cohort provided relatively more people with a known preference on (non)treatment decisions, allowing us to study the preferences in relation to actual decisions taken. However, the absolute numbers are low in subgroups. Another strength is that we selected people who had been in a specific medical situation for which a decision had to be taken (and not only people for whom preferences were known) allowing us to study the value of making preferences known.
CONCLUSION
Concordance between preferred and actual treatment is high in older people who prefer to receive treatment, and lower in people who prefer to forgo treatment. However, making preferences for forgoing treatment known is useful, as it increases the chance of treatments being forgone in those who wish so. Further research should look into the relation between following preferences and quality of palliative care.
